A detailed history of Jacob Asset Management Of New York LLC transactions in Omeros Corp stock. As of the latest transaction made, Jacob Asset Management Of New York LLC holds 55,168 shares of OMER stock, worth $475,548. This represents 0.23% of its overall portfolio holdings.

Number of Shares
55,168
Previous 80,168 31.18%
Holding current value
$475,548
Previous $436,000 63.07%
% of portfolio
0.23%
Previous 0.49%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 01, 2023

SELL
$2.81 - $5.69 $70,250 - $142,250
-25,000 Reduced 31.18%
55,168 $161,000
Q2 2023

Aug 10, 2023

SELL
$4.45 - $7.57 $71,200 - $121,120
-16,000 Reduced 16.64%
80,168 $436,000
Q1 2023

May 11, 2023

BUY
$2.48 - $5.22 $24,800 - $52,200
10,000 Added 11.61%
96,168 $447,000
Q4 2022

Feb 14, 2023

SELL
$1.75 - $3.96 $3,080 - $6,969
-1,760 Reduced 2.0%
86,168 $194,000
Q3 2022

Nov 10, 2022

SELL
$3.09 - $7.46 $12,360 - $29,840
-4,000 Reduced 4.35%
87,928 $277,000
Q2 2022

Aug 11, 2022

SELL
$1.92 - $6.28 $44,125 - $144,326
-22,982 Reduced 20.0%
91,928 $253,000
Q1 2022

May 12, 2022

SELL
$5.07 - $7.2 $258,635 - $367,293
-51,013 Reduced 30.74%
114,910 $691,000
Q4 2021

Feb 09, 2022

SELL
$5.67 - $8.54 $920,292 - $1.39 Million
-162,309 Reduced 49.45%
165,923 $1.07 Million
Q3 2021

Nov 12, 2021

SELL
$13.4 - $16.3 $516,811 - $628,658
-38,568 Reduced 10.51%
328,232 $4.53 Million
Q2 2021

Oct 04, 2021

BUY
$14.81 - $19.13 $2.04 Million - $2.64 Million
138,000 Added 60.31%
366,800 $5.44 Million
Q1 2021

Oct 04, 2021

BUY
$14.52 - $23.53 $1.79 Million - $2.89 Million
123,000 Added 116.26%
228,800 $4.07 Million
Q4 2020

Oct 04, 2021

BUY
$10.14 - $15.19 $1.07 Million - $1.61 Million
105,800 New
105,800 $1.51 Million

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $541M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Jacob Asset Management Of New York LLC Portfolio

Follow Jacob Asset Management Of New York LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacob Asset Management Of New York LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacob Asset Management Of New York LLC with notifications on news.